Traws Pharma Stock Forecast

Sell candidate since May 29, 2026 Loss -42.64%

The Traws Pharma, Inc. stock price fell by -6.09% on the last day (Tuesday, 23rd Jun 2026) from $0.89 to $0.84. During the last trading day the stock fluctuated 11.71% from a day low at $0.84 to a day high of $0.94. The price has been going up and down for this period, and there has been a -38.87% loss for the last 2 weeks. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 259 thousand shares were bought and sold for approximately $216.52 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.710 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.11% during the next 3 months and, with a 90% probability hold a price between $0.546 and $1.46 at the end of this 3-month period.

TRAW Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 15, 2026, and so far it has risen 10.81%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Traws Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.89 and $1.44. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Traws Pharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Traws Pharma, Inc. stock

Traws Pharma, Inc. finds support from accumulated volume at $0.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0981 between high and low, or 11.71%. For the last week, the stock has had daily average volatility of 14.14%.

Traws Pharma, Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TRAW) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Traws Pharma, Inc. to open at $0.87, and during the day (based on 14 day Average True Range), to move between $0.758 and $0.92, which gives a possible trading interval of +/-$0.159 (+/-20.98%) up or down from last closing price. If Traws Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 20.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.84 (0.20%) than the resistance at $0.85 (1.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Traws Pharma, Inc. stock A Buy?

Traws Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.618 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.87 ( 3.90%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk